Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	4.49	154.12	147.49
Graham Fair Price	0.00	6.38	6.38
PEG	inf	0.00	-0.01
Price/Book	13.51	0.41	0.36
Price/Cash Flow	13.51	12.34	10.87
Prices/Earnings	-13.51	-2.06	-1.81
Price/Sales	13.51	1.87	1.64
Price/FCF	13.51	12.34	10.87
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.26	0.26
Operating Margin	0.00	< 0.005	< 0.005
ROA	0.00	-0.02	-0.02
ROE	-0.05	-0.05	0.00
ROIC	< 0.005	< 0.005	0.85
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	-0.01	33.75
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.86	0.00	inf
EPS QOQ	-1.73	0.00	inf
FCF QOQ	0.09	0.00	inf
Revenue QOQ	0.34	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	45.24	45.24	0.00
Days Sales Outstanding (DSO)	345.35	345.35	0.00
Inventory Turnover	1.99	1.99	0.00
Debt/Capitalization	0.56	0.57	0.66
Quick Ratio	0.64	0.64	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	6.04	6.04	0.00
Cash	0.79	0.79	0.00
Capex	-0.08	-0.08	0.00
Free Cash Flow	0.20	0.20	0.00
Revenue	1.32	1.32	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.79	0.79	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	112.48	114.38	1.69
Naive Interpretation	Member

06 - Financial Health · Bad

Rating